Nov 09, 2020 / 09:30PM GMT
Operator
Good afternoon, everyone, and welcome to today's Neurocrine Biosciences Reports Third Quarter 2020 Results. (Operator Instructions) Please note, this call may be recorded. (Operator Instructions) It is now my pleasure to turn today's program over to Todd Tushla, Vice President of Investor Relations. Please go ahead.
Todd Tushla - Neurocrine Biosciences, Inc. - VP of IR
Great. Thanks, Jamie. Good afternoon, everyone, and thank you for joining our third quarter 2020 earnings call. Joining me on the call is Kevin Gorman, our Chief Executive Officer; Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; and Kyle Gano, our Chief Business Development and Strategy Officer.
During today's call, we'll be making forward-looking statements. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to review the risk factors discussed in our latest SEC filings. Following our prepared remarks, we will open the call up for
Q3 2020 Neurocrine Biosciences Inc Earnings Call Transcript
Nov 10, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers